Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



GenMark Diagnostics Catches Analysts Sleeping Again

GenMark Diagnostics (Nasdaq: GNMK  ) reported earnings on Nov. 7. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), GenMark Diagnostics crushed expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue grew significantly and GAAP loss per share dropped.

Margins increased across the board.

Revenue details
GenMark Diagnostics logged revenue of $5.3 million. The three analysts polled by S&P Capital IQ wanted to see revenue of $4.3 million on the same basis. GAAP reported sales were much higher than the prior-year quarter's $1.3 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at -$0.20. The three earnings estimates compiled by S&P Capital IQ averaged -$0.20 per share. GAAP EPS were -$0.20 for Q3 compared to -$0.31 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 42.4%, 7,800 basis points better than the prior-year quarter. Operating margin was -118.6%, 34,530 basis points better than the prior-year quarter. Net margin was -118.9%, 36,080 basis points better than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $5.6 million. On the bottom line, the average EPS estimate is -$0.19.

Next year's average estimate for revenue is $15.6 million. The average EPS estimate is -$0.95.

Investor sentiment
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 10 members out of 11 rating the stock outperform, and one members rating it underperform. Among three CAPS All-Star picks (recommendations by the highest-ranked CAPS members), two give GenMark Diagnostics a green thumbs-up, and one give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on GenMark Diagnostics is buy, with an average price target of $9.17.

Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 14, 2012, at 10:20 AM, geoslv wrote:

    This stock movement is too hard to predict.

    And now it has hanky-panky manipulation by Wall St causing flash crashes triggering stop losses.

    As for the company, when their tests cost less than $1000 they will start to be covered by insurance plans, and it will mushroom. Does anyone know the cost now?

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2110240, ~/Articles/ArticleHandler.aspx, 5/29/2016 3:51:38 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 17,873.22 44.93 0.25%
S&P 500 2,099.06 8.96 0.43%
NASD 4,933.51 31.74 0.65%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/27/2016 4:00 PM
GNMK $7.32 Up +0.17 +2.38%
GenMark Diagnostic… CAPS Rating: No stars